1. Australia Stocks

  2. •

    Health technology

  3. •

    Biotechnology
Identifai Genetics Limited

Identifai Genetics Limited

AASX:ID1
0.49
AUD
-0.01
(-3.00%)
Identifai Genetics Limited
ASX:ID1
(Australian Securities Exchange)

Recent

price

0.49

P/E

ratio

- -

div

yld

- -

ROIC.AI

No data availableFinancial data will appear here once available

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Semi-annual Revenue

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Semi-annual Earnings Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Semi-annual Dividends Per Share

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available
Similar Companies
Moderna, Inc. (NASDAQ:MRNA)
Amgen Inc. (NASDAQ:AMGN)
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA)
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX)
Novavax, Inc. (NASDAQ:NVAX)
10x Genomics, Inc. (NASDAQ:TXG)
Business
IdentifAI Genetics Ltd. engages in the development, validation, and commercial validation of a genome-wide non-invasive prenatal screening platform. The company was founded by Noam Shomron, Tom Rabinowitz, Oren Tadmor, Kobi Caspi, and Yoseph Bornstein on April 12, 2021 and is headquartered in Subiaco, Australia.